Karakas, A. Et Al. 2024. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry. MODERN RHEUMATOLOGY , vol.34, no.3 , 584-591.

Karakas, A., Gulle, S., CAN, G., DALKILIÇ, H. E., AKAR, S., KOCA, S. S., ... PEHLİVAN, Y.(2024). Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry. MODERN RHEUMATOLOGY , vol.34, no.3, 584-591.

Karakas, Ali Et Al. "Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry," MODERN RHEUMATOLOGY , vol.34, no.3, 584-591, 2024

Karakas, Ali Et Al. "Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry." MODERN RHEUMATOLOGY , vol.34, no.3, pp.584-591, 2024

Karakas, A. Et Al. (2024) . "Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry." MODERN RHEUMATOLOGY , vol.34, no.3, pp.584-591.

@article{article, author={Ali Karakas Et Al. }, title={Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry}, journal={MODERN RHEUMATOLOGY}, year=2024, pages={584-591} }